📰 Michael Ackermann News
Michael Ackermann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Ackermann. Real-time updates on events, politics, business and more.
July 16, 2024
Yielding around where it had been. 8 is roughly the mark weve been sitting at. It looks like the 10year is yielding as well i know people are short and anxious. These two days backtoback are we putting in a bottom these numbers in new york look promising like the numbers may not be going up as rapidly as imagined well see. We have a lot of big guests to talk about that. We want to get everybody up to date about what happened last night. The Senate Passing that stimulus bill it now goes to the se...
July 5, 2023
Irvine based Tarsus Pharmaceuticals drugmaker works to provide a fun environment by hosting events that promote a positive team culture.
April 20, 2023
Ratcliffe has brought investment in players and infrastructure to Nice, and there are mixed feelings in France about his latest venture
May 29, 2022
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 386,800 shares, a decrease of 32.2% from the April 30th total of 570,200 shares. Based on an average daily volume of 151,200 shares, the […]
May 26, 2022
Wall Street brokerages predict that Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) will report $16.67 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Tarsus Pharmaceuticals’ earnings, with estimates ranging from $15.00 million to $20.00 million. Tarsus Pharmaceuticals reported sales of $22.02 million during the same […]
December 14, 2021
RESEARCH TRIANGLE PARK - Five years after launching with a team headlined by local life sciences "rainmaker" Steve Butts and $49 million in capital, Arrivo
December 13, 2021
Five years after launching with a team headlined by local life sciences “rainmaker” Steve Butts and $49 million in capital, Morrisville-based Arrivo BioVentures is emerging from stealth mode with four drugs in its pipeline.
August 12, 2021
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development in the pharmaceutical and healthcare...
May 14, 2021
NEW YORK, May 14, 2021 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of